5

PRIMARY DOCUMENT

Company: REGENERON PHARMACEUTICALS, INC.
Filed: February 7, 2013
Period of Report: December 31, 2012
Accession Number: 0001237899-13-000014

View Document ↗ View on SEC.gov ↗